Australia markets open in 2 hours 3 minutes

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
11.60-0.22 (-1.86%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.73B
Enterprise value 5.77B
Trailing P/E 49.25
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.59
Price/book (mrq)4.11
Enterprise value/revenue 3.19
Enterprise value/EBITDA 43.05

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-28.45%
S&P500 52-week change 328.04%
52-week high 320.09
52-week low 39.51
50-day moving average 312.08
200-day moving average 314.16

Share statistics

Avg vol (3-month) 33.12M
Avg vol (10-day) 32.4M
Shares outstanding 5400.11M
Implied shares outstanding 6407.7M
Float 8142.09M
% held by insiders 179.12%
% held by institutions 10.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 423 June 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.25%
Operating margin (ttm)9.04%

Management effectiveness

Return on assets (ttm)2.43%
Return on equity (ttm)9.12%

Income statement

Revenue (ttm)1.81B
Revenue per share (ttm)4.56
Quarterly revenue growth (yoy)-18.40%
Gross profit (ttm)N/A
EBITDA 157.58M
Net income avi to common (ttm)94.97M
Diluted EPS (ttm)0.24
Quarterly earnings growth (yoy)-28.40%

Balance sheet

Total cash (mrq)251.17M
Total cash per share (mrq)0.63
Total debt (mrq)1.29B
Total debt/equity (mrq)108.19%
Current ratio (mrq)1.08
Book value per share (mrq)2.87

Cash flow statement

Operating cash flow (ttm)-43.86M
Levered free cash flow (ttm)-499.35M